BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/11/2014 8:39:00 PM | Browse: 963 | Download: 547
Publication Name World Journal of Gastroenterology
Manuscript ID 3491
Country Germany
Received
2013-05-02 09:58
Peer-Review Started
2013-05-02 15:05
To Make the First Decision
2013-06-09 09:58
Return for Revision
2013-06-20 20:11
Revised
2013-08-15 03:56
Second Decision
2013-09-29 12:32
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-09-29 22:18
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-12-19 17:28
Publish the Manuscript Online
2014-01-14 20:11
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Autobiography
Article Title Inhibitor of differentiation proteins do not influence prognosis of biliary tract cancer
Manuscript Source Invited Manuscript
All Author List Jan Harder, Michael J Müller, Matthias Fuchs, Vera Gumpp, Annette Schmitt-Graeff, Richard Fischer, Melanie Frank, Oliver Opitz and Jens Hasskarl
Funding Agency and Grant Number
Corresponding Author Jan Harder, MD, Department of Gastroenterology, Hematology and Oncology, Hegau-Bodensee-Hochrhein Kliniken, Virchowstraße 10, 78221 Singen, Germany. jan.harder@hbh-kliniken.de
Key Words Biliary tract cancer; Cholangiocarcinoma; Inhibitor of differentiation; Prognostic factors
Core Tip Cholangiocarcinoma present as heterogeneous tumors with generally poor prognosis. Molecular changes that drive tumor development are poorly understood, and no valid prognostic markers other than stage and performance status have been identified. Here we analyzed the protein expression of the four inhibitor of differentiation (ID)-proteins by immunohistochemistry in 129 patients with advanced biliary tract cancer, which showed a deregulated ID protein expression in cancer cells and this protein expression partly correlated with the overall survival of patients. Therefore the ID-proteins maybe useful prognostic markers.
Publish Date 2014-01-14 20:11
Citation Harder J, Müller MJ, Fuchs M, Gumpp V, Schmitt-Graeff A, Fischer R, Frank M, Opitz O, Hasskarl J. Inhibitor of differentiation proteins do not influence prognosis of biliary tract cancer. World J Gastroenterol 2013; 19(48): 9334-9342
URL http://www.wjgnet.com/1007-9327/full/v19/i48/9334.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i48.9334
Full Article (PDF) WJG-19-9334.pdf
Manuscript File 3491-Review.doc
Answering Reviewers 3491-Copyright assignment.pdf
Copyright License Agreement 3491-Copyright assignment.pdf
Institutional Review Board Approval Form or Document Ethikvotum.pdf
Peer-review Report 3491-Peer review(s).pdf
Scientific Editor Work List 3491-Scientific editor work list.doc